• University of Huddersfield
    Queensgate
    Huddersfield
    HD1 3DH

    United Kingdom

Accepting PhD Students

PhD projects

Click on the Fingerprint icon below to learn more about the research topics, expertise and interests of this academic.

Calculated based on number of publications stored in Pure and citations from Scopus
1987 …2024

Research activity per year

Personal profile

Research Degree Supervision

If you are interested in studying for a PhD in this research subject area click here 

For more details about the research topics, expertise and interests of this academic, click on the fingerprint icon

Google Scholar h-Index

45 from 6,368 citations 

Last updated 17th April 2024

Biography

Professor Roger Phillips was appointed Professor of Cancer Pharmacology in July 2014.

Following a BSc in Marine Biology and Biochemistry (Joint Honours) from University College of North Wales, Bangor, Roger specialised in Cancer Pharmacology gaining his PhD in 1988 from the University of Bradford (under Profs John Double and Mike Bibby). After an initial postdoctoral position in Bradford, he moved to the School of Pharmacy, University of Southern California, Los Angeles to work with Dr Neil Gibson in 1991. He returned to Bradford in 1993 and secured academic appointments as lecturer (1996 to 2001), Senior Lecturer (2001 to 2003) and Reader (2003 to 1014) in Cancer Pharmacology. In July 2014, Roger was appointed as Professor of Cancer Pharmacology at the University of Huddersfield. He was also appointed as Director of Research in the School of Applied Sciences in August 2015.

His research focuses on the preclinical and early clinical evaluation of novel anti-cancer drugs with a specific interest in the tumour microenvironment as a target for drug development. His research has had clinical impact through the development of EO9 as a therapeutic drug for the treatment of superficial bladder cancer. He has published extensively in internationally recognised journals, has successfully supervised over 20 PhD students and continues to present his work at national and international conferences. He is a committee member of the European Organisation for the Research and Treatment of Cancer (EORTC) Drug Development Committee and the Pharmacology and Molecular Mechanism Group. He is also an editorial board member for the British Journal of Pharmacology. 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities

Research Expertise and Interests

  • Biochemistry
  • Molecular Medicine
  • Cancer Research
  • Drug Development
  • Biomarker Research
  • Pharmaceutics
  • Preclinical development of novel anti-cancer drugs
  • Phenotype based screening
  • Development of experimental models that reflect the complexity of tumour biology
  • The hypoxic tumour microenvironment as a target for drug development
  • Drug delivery to hypoxic regions of solid tumours

Fingerprint

Dive into the research topics where Roger Phillips is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or